您所在的位置: 首页 --> 导师团队 --> 王崑

导师基本信息

  • 姓名:王崑
  • 性别:
  • 民族:汉族
  • 科室:肝胆胰外科-I
  • 职称:主任医师 ,副教授
  • 专业:肿瘤学 、肿瘤外科学
  • E-MAIL: wang-kun@vip.sina.com

学术论文 | 科研项目 | 招生计划

Jin KM, Liu W, Wang K, Bao Q, Wang HW and Xing BC. The individualized selection of Pancreaticoenteric anastomosis in Pancreaticoduodenectomy [J]. BMC Surg, 2020, 20(1): 140.,BMC Surg,2020, 20(1): 140.

Wang LJ, Yan XL, Li J, Wang K and Xing BC. Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis [J]. Cancer Manag Res, 2020, 12: 3237-3245.,Cancer Manag Res,,2020, 12: 3237-3245.

Wang YY, Xiang BD, Ma L, Zhong JH, Ye JZ, Wang K, Xing BC and Li LQ. Development and Validation of a Nomogram to Preoperatively Estimate Post-hepatectomy Liver Dysfunction Risk and Long-term Survival in Patients With Hepatocellular Carcinoma [J]. Ann Surg, 2020.,Ann Surg,

Liu W, Wang K#, Han Y, Liang JY, Li YH, Xing BCNomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection,Eur J Surg Oncol,2019 Nov;45(11):2070-2077

Wang YY, Liu ZZ, Xu D, Liu M, Wang K and Xing BC. Fibrinogen-Albumin Ratio Index (FARI): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases [J]. Ann Surg Oncol, 2019, 26(11): 3682-3692,Ann Surg Oncol,2019, 26(11): 3682-3692

Da X,XiaoFeng L, Wang K(corresponding)et al. Survival prediction in patients with resectable colorectal liver metastases: Clinical risk scores and tumour response to chemotherapy. Oncology letters 2017 Oct,Oncology letters,2017;14:8051-59

Kun Wang, Wei Liu, Xiao-Luan Yan, Juan Li and Bao-Cai Xing. Long-term postoperative survival prediction in patients with colorectal liver metastasis. Oncotarget. 2017; 8:79927-79934,Oncotarget,2017epub

Role of a liver-first approach for synchronous colorectal liver metastases. Wang K, Liu W, Yan XL, Xing BC,World J Gastroenterol.,2016 Feb 14;22(6):2126-32

可切除的结直肠肝转移的高危人群(CRS≧3),围手术期化疗联合西妥昔单抗与单纯化疗的疗效比较(前瞻非随机对照研究), 课题负责人 , 2016.5.1~2018.12.31, CSCO

可切除的结直肠肝转移的高危人群(CRS≥3)预后复发因素分析,及围手术期化疗联合西妥昔单抗与单纯化疗的疗效比较 , 课题负责人 , 2016.1.1~2018.12.31, 北京市医管局 pX2016002

研究生招生计划
招生年度 招生专业 学位级别 学位类型 研究方向 选拔方式
2021 肿瘤学 硕士 科学学位 结直肠癌肝转移机制研究 推荐免试
2021 肿瘤外科学 长学制 专业学位 临床技能训练与研究 长学制二级学科培养
2021 肿瘤学 博士 科学学位 结直肠癌肝转移机制研究 申请考核制